Antipodes Partners’ Q1 2026 investor letter put a spotlight on Keysight Technologies after a strong quarter, noting earnings beats, order momentum, and a clearer outlook tied to AI and defence demand. The firm described how market gyrations and sector rotations shaped performance, and it adjusted exposures to manage risk as conditions shifted.
Antipodes called out Keysight Technologies, Inc. (KEYS) as a meaningful contributor in the quarter, citing demand across communications, aerospace and semiconductor testing. Keysight builds electronic design and test solutions used by communications firms, chip makers and aerospace and defense contractors. That product mix gave it exposure to several structural upgrades in technology spending.
By June 24, 2026, Keysight shares closed near $351.30, with a one-month return around 3.6% and an eye-catching 52-week gain north of 110%. The company’s market capitalization sits in the tens of billions, reflecting fast growth and strong investor interest. Those gains followed a string of positive operational beats that reinforced the stock’s momentum.
Antipodes Global Value Strategy stated the following regarding Keysight Technologies, Inc. (NYSE:KEYS) in its Q1 2026 investor letter:
“Electronics testing company Keysight Technologies, Inc. (NYSE:KEYS) pushed higher following a Q1 FY26 earnings beat and raised outlook. The company reported revenue and EPS exceeding forecasts, demonstrating accelerating demand across communications, aerospace/defence and semiconductor testing markets. Results were supported by strong order growth (~22 % year-on-year) and improving backlog, which led to an uplift in earnings expectations. Management highlighted structural drivers including AI infrastructure, next-generation connectivity and defence modernisation as key tailwinds.”
The quote captures the core thesis: better-than-expected quarterly results, rising orders and a backlog that supports near-term visibility. Management’s emphasis on AI infrastructure and next-generation connectivity resonated with investors hunting durable secular trends. Defence modernisation added a cyclical lift at the same time.
Operationally, the company reported revenue expansion that reflected both organic strength and favorable end-market dynamics. Antipodes highlighted order growth near 22% year-on-year, which helped justify upgraded earnings assumptions. The improving backlog provided a clearer runway for the next several quarters.
Institutional interest has been moving in tandem: more hedge funds disclosed positions in Keysight during the latest quarter, signaling growing conviction among active managers. Revenue in the most recent reported period rose markedly year-over-year, showing the business is converting demand into top-line growth. That institutional accumulation and sales traction underpinned the stock’s recent run.
That said, investors should watch cyclicality and concentration risks tied to tech cycles and defence budgets, along with valuation after a powerful rally. Antipodes managed exposure by leaning into defensive sectors at points during the quarter to protect capital amid volatility. For traders and long-term holders alike, the setup feels like a blend of structural tailwinds and short-term sensitivity to macro shocks.
